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Although therapeutic anticoagulation remains
the standard treatment for acute deep venous
thrombosis (DVT),1 adjuncts, such as compression
stockings2 and thrombolytic therapy,3 may be
appropriate for patients who are at risk for long-term
complications. Unfortunately, the presenting fea-
tures of a thrombotic event often have not correlat-
ed with the development of the 2 major complica-
tions of acute DVT, pulmonary embolism, and the
post-thrombotic syndrome. Menzoin et al4 found
no relationship between the anatomic location of
thrombus and pulmonary embolism, and most
investigators5-7 have found the extent of acute
thrombosis to be unrelated to the development of
post-thrombotic manifestations. After finding no
relationship between total or most proximal throm-
bus extent and the severity of post-thrombotic
symptoms, Browse et al5 concluded that the devel-
opment of the post-thrombotic syndrome was
“totally unpredictable.”
Because severe manifestations of the post-throm-
botic syndrome often do not develop for years after
an episode of acute DVT, the ability to predict late
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Purpose: The purpose of this investigation was to evaluate the relationship between the
presenting features of an acute deep venous thrombosis (DVT), the subsequent natural
history of the thrombus, and the ultimate outcome as defined according to the Society
for Vascular Surgery and the North American Chapter of the International Society for
Cardiovascular Surgery reporting standards in venous disease.
Methods: Patients with an acute DVT were followed with serial clinical and ultrasound
examinations. Thrombus extent within 7 venous segments was scored retrospectively
according to the reporting standards (scores ranged from 0 to 3), and segmental reflux
was scored as present (1) or not present (0). The initial and final thrombus scores, the
rates of recanalization and rethrombosis, and the total reflux scores were then calculat-
ed from these grading scales and related to ultimate chronic venous disease (CVD) clas-
sification.
Results: Sixty-eight patients with an acute DVT in 73 limbs were followed for 18 to 110
months (mean, 55 ± 26 months). At the completion of the follow-up period, 20 extrem-
ities (27%) were asymptomatic (class 0), 13 (18%) had pain or prominent superficial
veins (class 1), 25 (34%) had manifested edema (class 3), 13 (18%) had developed hyper-
pigmentation (class 4), and 2 (3%) had developed ulceration (class 5). In a univariate
analysis, CVD classification was correlated with the reflux score (P = .003) but not with
the initial or final thrombus score or with the rate of recanalization or rethrombosis. In
a multivariate model of features documented at presentation, only the tibial thrombosis
score was a significant predictor of CVD classification (R2 = .06). Outcome was better
predicted (R2 = .29) with a model that included variables defined during follow-up—the
final reflux score, the final popliteal score, and the rate of recanalization.
Conclusion: The ability to predict the severity of CVD after an acute DVT is currently
limited, although the natural history appears more important than the presenting fea-
tures of the event. The extent of reflux, the presence of persistent popliteal obstruction,
and the rate of recanalization are related to ultimate CVD classification, but other deter-
minants remain to be identified. (J Vasc Surg 1998;28:826-33.)
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outcome would be useful in understanding the
underlying pathophysiology and in evaluating the
effectiveness of and indications for adjunctive thera-
peutic measures. Under the auspices of the Society
for Vascular Surgery and North American Chapter of
the International Society for Cardiovascular Surgery
(NA-ISCVS/SVS), an international consensus com-
mittee has developed reporting standards for acute
and chronic venous disease (CVD).8 Components of
the reporting standards for acute DVT include the
numerical scoring of thrombotic risk factors, a
description of thrombus location and extent, and a
definition of the diagnostic and therapeutic stan-
dards. The standards for CVD include a classification
system that is on the basis of the clinical signs, the
causes, the presence of reflux or obstruction, and the
anatomic sites of these abnormalities. Although the
primary intent of the consensus committee was stan-
dardization of the descriptive features of a patient’s
presentation, the reporting standards also provide a
framework for quantitatively examining the relation-
ship between the presenting features of an acute
DVT and the subsequent development of the post-
thrombotic syndrome.
The purpose of this investigation was to evaluate
the relationship between the presenting features of a
thrombotic event, the quantitative changes that
occur in the venous system over time, and the long-
term outcome as described according to the NA-
ISCVS/SVS reporting standards.
METHODS
All patients who were seen at the University of
Washington Medical Center with a first episode of
acute DVT confirmed with duplex ultrasound were
asked to participate in a longitudinal study of the nat-
ural history of acute DVT. Patients with a history of
DVT or with clinical evidence of CVD were excluded
from enrollment. Subjects consenting to participate
were asked to return at the following intervals: 1 day,
7 days, 1 month, every 3 months for 1 year, and year-
ly thereafter. Because precise scheduling was often dif-
ficult, the visits that occured on the scheduled date ±
half of the length of the interval between the visits
were considered to be representative of that study visit.
At each visit, the subjects were questioned regarding
both new DVT symptoms and ongoing limb pain,
ache, or heaviness. Their lower extremities were exam-
ined, and duplex ultrasound of the lower extremity
venous system was performed. The study protocol was
approved by the Human Subjects Committee at the
University of Washington, and informed consent was
obtained from all subjects.
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Duplex examinations were performed in 15-
degrees reverse Trendelenburg position with an
Ultramark 8 or 9 instrument (Advanced Technology
Laboratories, Bothell, Wash), with a 5-MHz trans-
ducer for the proximal venous segments and a 10-
MHz transducer for the calf veins. All examinations
were performed by a technologist dedicated to the
study, and the results were evaluated prospectively in
comparison with previous studies. The following
venous segments were evaluated: the inferior vena
cava; the common and external iliac veins; the com-
mon femoral vein (CFV); the profunda femoris
vein; the proximal, mid, and distal superficial
femoral veins (SFV); the proximal and distal
popliteal veins (PPV); the peroneal and posterior
tibial veins; and the greater saphenous vein (GSV).
Each venous segment was defined as being patent,
partially occluded, or completely occluded on the
basis of the B-mode imaging and Doppler ultra-
sound criteria. Valvular incompetence was evaluated
by the response to Valsalva’s maneuver and to limb
compression and was defined as a reverse flow per-
sisting for greater than 2 seconds. Depending on
the venous segment, this definition of reflux has
been shown to have an accuracy rate of 74% (CFV)
to 92% (PPV) in comparison with the standing cuff
deflation method.9
Because the intent of the current investigation
was the examination of the determinants of post-
thrombotic syndrome, only subjects who were fol-
lowed beyond their 2nd yearly visit (24 ± 6 months)
were included in the analysis. A thrombotic score
was calculated retrospectively for each involved limb
according to a modification of the NA-ISCVS/SVS
grading scale.8 According to the NA-ISCVS/SVS
reporting standards, each of the 6 deep and the 2
superficial venous segments are assigned the follow-
ing scores: 0 for a patent segment, 1 for a subseg-
mental nonocclusive thrombus, 2 for a subsegmen-
tal occlusive thrombus, and 3 for an occlusive
thrombus throughout the length of a segment.
Segments to be scored include the inferior vena
cava, the iliac vein, the CFV, the SFV, the PPV, the
tibial-soleal veins, the GSV, and the lesser saphenous
vein. Because the lesser saphenous vein was not eval-
uated prospectively in this study, only the 6 deep
venous segments and the GSV were included in the
calculation of the modified thrombotic score.
Therefore, the maximum score for each limb was 21
rather than 24. If technical factors, such as bowel gas
or edema, prevented adequate visualization of the
iliac or the tibial veins at the first visit, the first fol-
low-up visit at which the segment could be ade-
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quately imaged was considered to represent the
baseline score for that segment. Similarly, if a seg-
ment was not adequately visualized at the last fol-
low-up visit, the value at the last preceding visit at
which the segment was adequately visualized was
assigned as the final thrombus score. The thrombot-
ic scores at each visit then were used to determine
the percentage recanalization, the time to a 50%
reduction in thrombus score, and the occurrence of
recurrent thrombotic events. Valvular reflux also was
quantified for each segment—a score of 0 was
assigned if reflux was absent, and 1 was assigned if
reflux was present—and summed to derive a total
reflux score with a maximum value of 7.
Post-thrombotic manifestations at the time of the
last follow-up visit were classified according to the
updated reporting standards in venous disease. The
classifications were as follows: class 0, no clinical evi-
dence of venous disease; class 1, the presence of
telangiectasias, reticular veins, or malleolar flare; class
2, the development of varicose veins; class 3, the
presence of edema without skin changes; class 4, the
development of hyperpigmentation or lipoder-
matosclerosis; class 5, the presence of skin changes
with healed ulceration; and class 6, the presence of
skin changes with active ulceration. Symptoms of
pain or heaviness frequently are recognized as mild
post-thrombotic symptoms,2,10 and the reporting
standards have noted the relationship between such
symptoms and abnormal superficial veins.8 Subjective
complaints of pain without visible manifestations of
CVD therefore were included in class 1.
CVD classification within an extremity was the
primary outcome evaluated and was considered to be
a continuous variable. Although a few patients (n =
5) contributed 2 extremities to the study, analyses
controlling for the dependence of paired extremities
differed little from those on the basis of an assump-
tion of independence. Only the results that assumed
independence are presented. The potential determi-
nants of CVD classification were considered to
include the thrombotic risk factors (Table I), the
thrombotic score at initial presentation and the last
follow-up visit, the time interval to a 50% reduction
in thrombotic score, recurrent thrombotic events,
and the reflux score at the last follow-up visit.
Statistical analysis was performed with SPSS software
(SPSS Inc, Chicago, Ill) with unpaired t tests to com-
pare the mean classification among the groups and
the Spearman rank correlation coefficient to evaluate
the relationship between the natural history determi-
nants and CVD classification. Variables that were sig-
nificant at a level of P ≤ .10 then were entered into a
stepwise multivariate regression model. Except where
otherwise noted, all the data are reported as the
mean ± the standard deviation of the mean. Statistical
significance was defined as P ≤ .05.
RESULTS
Between January 1987 and January 1995, 176
patients with a first episode of acute DVT were
enrolled in the follow-up study. Among those
enrolled, 68 patients with an acute DVT in 73
extremities were followed until at least their scheduled
2-year study visit. These patients constitute the study
group. The gender distribution was equal (34 of each
gender), and the mean age was 48.8 years (standard
deviation ± 18.5 years). Subjects had a mean of 1.0 
(± 0.9) risk factors for DVT: 23 subjects (31.5%) had
no risk factors, 26 (35.6%) had 1 risk factor, 22
(30.1%) had 2 risk factors, and 2 (2.7%) had 3 risk fac-
tors. The acute DVT was isolated to the calf veins in
5 extremities (6.8%) and involved the proximal veins,
with or without the calf veins, in 68 limbs (93.2%).
Thrombosis was unilateral on the right side in 26
patients (38%), unilateral on the left side in 37
patients (54%), and bilateral in 5 patients (7%).
The 73 extremities were followed for 18 to 110
Table I. Risk factor determinants of chronic venous disease classification
Present Absent
Risk factor n Class (mean ± SE) n Class (mean ± SE) P†
Surgery 22 1.7 (± 0.31) 47 2.3 (± 0.24) .15
Bedrest 22 1.9 (± 0.32) 47 2.2 (± 0.24) .4
Malignant disease 16 1.6 (± 0.38) 52 2.3 (± 0.22) .11
Family history 10 1.7 (± 0.50) 53 2.2 (± 0.22) .4
Congestive heart failure 4 2.3 (± 0.75) 68 2.1 (± 0.20) .86
Pregnancy 2 0.5 (± 0.50) 68 2.2 (± 0.20) .15
Oral contraceptives 0 — 66 2.2 (± 0.20) —
SE, Standard error of the mean.
*P value determined with unpaired t test.
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months, with a mean follow-up time of 55 ± 26
months. The mean thrombus score decreased from
6.9 ± 4.2 at the time of presentation to 1.2 ± 1.8 at
the time of the last follow-up visit. Recanalization, as
evidenced by a decrease in thrombus score, was pre-
sent in 69 extremities (94.5%), with a mean reduc-
tion in thrombus score of 85.5% ± 20.8%. Among
the other 4 extremities, the mean thrombus score
was unchanged from presentation in 2 and had
increased in 2 limbs. The rate of recanalization was
expressed as the time to a 50% reduction in the ini-
tial thrombus score. Among the patients who
achieved 50% recanalization, this occurred a mean of
3.4 ± 5.9 months after presentation. A trend toward
earlier recanalization in female patients (mean time
to 50% recanalization, 2.6 ± 3.3 months) than in
male patients (mean time to 50% recanalization, 4.9
± 7.7 months) was present but failed to reach statis-
tical significance (P = .1). Recurrent thrombotic
events, as defined by an interval increase in total
thrombus score between consecutive study visits,
were noted in 47 limbs (64.4%). However, as
recanalization and recurrent thrombotic events fre-
quently occurred simultaneously in the same limb,
the total thrombus score was a poor marker of new
thrombotic events within individual venous seg-
ments. This is illustrated by the observation that,
when defined as an increase in any individual seg-
ment score, recurrent thrombotic events were
observed in 59 extremities (80.8%). The mean reflux
score at the final visit was 2.0 ± 1.7.
At the completion of the follow-up period, 20
limbs (27.4%) were asymptomatic (class 0), 13
(17.8%) had pain or prominent superficial veins (class
1), 25 (34.2%) manifested edema (class 3), 13
(17.8%) developed hyperpigmentation (class 4), and 2
(2.7%) had healed ulcers (class 5). Varicose veins (class
2) were not observed in any extremity, and there were
no active ulcers (class 6). The outcomes in the right
(mean CVD classification, 2.0 ± 1.7) and the left
(mean CVD classification, 2.1 ± 1.6, P = .8) lower
extremities were not significantly different. The mean
CVD classification was lower in female patients (1.8 ±
1.4) than in male patients (2.4 ± 1.7), although this
difference was not statistically significant (P = .1).
However, male patients were significantly more likely
to have advanced signs of hyperpigmentation or ulcer-
ation than were female patients (32.4% vs 8.3%; P =
.01). None of the risk factors for acute thrombosis
(Table I) were significantly associated with ultimate
disease classification.
The initial thrombotic score was not significant-
ly correlated with the disease classification in the
univariate analysis (Table II). Among the 7 individ-
Fig 1. Mean initial thrombotic scores stratified by chronic venous disease classification in
lower extremity venous segments. Correlation with chronic venous disease classification is sta-
tistically significant for the tibial veins (r = .2; P = .05), with a trend present in the popliteal
vein (r = .2; P = .09). ILV, Iliac vein; CFV, common femoral vein; SFV, superficial femoral vein;
PPV, popliteal vein; TBV, tibial vein; GSV, greater saphenous vein.
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ual venous segments, only the initial tibial vein score
was significantly correlated with the ultimate disease
classification (r = .2; P = .05). The correlation
between the initial popliteal score and the outcome
did, however, approach statistical significance (r =
.2; P = .09; Fig 1). The initial thrombotic score was
correlated with the final reflux score (r = .5; P <
.0005), which among the potential natural history
determinants of outcome was most significantly cor-
related with CVD classification among the potential
natural history determinants of outcome (Table II).
Although total final thrombotic score was unrelated
to CVD classification, persistent obstruction of
some segments was important. Among individual
venous segments, final popliteal vein score was sig-
nificantly correlated with CVD classification (r = .3;
P = .01), and final tibial score approached signifi-
cance (r = .2; P = .08; Fig 2). Rethrombosis and the
time to 50% recanalization were not significantly
correlated with ultimate disease classification in the
univariate analysis.
On the basis of the univariate analysis, the poten-
tial determinants of the ultimate CVD classification
were entered into stepwise multiple regression mod-
els (Table III). This first was done with only those
factors—gender and initial popliteal and tibial
thrombosis scores—that could be determined at the
time of presentation and that showed a marginally or
statistically significant (P ≤ .10) association with the
disease classification. In this model, only the initial
tibial thrombosis score significantly predicted the
ultimate disease classification (R2 = .06; P = .04).
All presentation variables and potential natural his-
tory determinants of classification, including gen-
der, final thrombotic score, initial and final popliteal
and tibial thrombosis scores, percentage recanaliza-
tion, time to 50% recanalization, and final reflux
score were then entered into a second model. 
In this model (R2 = .29; P = .0002), the final
popliteal score (P = .01), the final reflux score 
(P = .008), and the time to 50% recanalization (P
=.06) were retained as predictors of the ultimate
disease classification.
DISCUSSION
Adjuncts to standard anticoagulation treatment
of acute DVT, such as compression stockings2 and
thrombolytic therapy,3 have been proposed as mea-
sures to minimize the long-term consequences of
the post-thrombotic syndrome. However, such mea-
sures are costly, are potentially associated with com-
plications, and may be unnecessary in the one third
of the patients in whom post-thrombotic sequelae
did not develop.11 Unfortunately, unlike the stag-
Fig 2. Mean final thrombotic scores stratified by chronic venous disease classification in lower
extremity venous segments. Correlation with chronic venous disease classification is statistical-
ly significant for the popliteal vein (r = .3; P = .01), with a trend present in the tibial veins 
(r = .2; P = .08). ILV, Iliac vein; CFV, common femoral vein; SFV, superficial femoral vein;
PPV, popliteal vein; TBV, tibial vein; GSV, greater saphenous vein.
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ing, stratification, or scoring systems used in malig-
nant disease,12 arterial disease,13 and trauma,14
methods of quantifying prognosis after an episode of
acute DVT do not exist. Reporting standards in
venous disease8,15 have been created to describe
important clinical features of acute and CVD and to
provide an obvious starting point for examining the
relationship between acute presentation and long-
term outcome.
The extent of thrombosis is perhaps the most eas-
ily quantified feature of an acute DVT, and several
systems for scoring the extent of thrombus have been
proposed. The acute DVT grading system proposed
as a component of the NA-ISCVS/SVS reporting
standards in venous disease assigns equal weight to
each of 6 deep and 2 superficial venous segments
scored according to the extent of occlusion. Other
systems have been proposed on the basis of either the
quantitative volume or the perceived physiologic
importance of the individual venous segments.
Marder et al16 proposed a 40-point scale in which the
SFV and the tibial veins were scored higher on the
basis of their greater volume, and Browse et al5
devised a 10-point phlebographic scoring system that
gave relatively greater weight to the pelvic veins.
Although such systems may have some use in follow-
ing the course of a thrombus, most investigators have
not found a clear relationship between the extent of
thrombus on initial presentation and the ultimate
clinical outcome.5-7,17,18
As is consistent with earlier phlebographic studies,
this study suggests that the ultrasound–determined
extent of thrombosis scored according to the NA-
ISCVS/SVS grading scale is also a poor predictor of
the ultimate CVD classification. It is important to
recognize that this grading system was designed only
to quantify the extent of thrombosis, not to predict
outcome, and this investigation points out the prob-
lems inherent in using such an approach. Most
importantly, it is clear that the lower extremity
venous segments differ with respect to their contri-
bution to the post-thrombotic syndrome. Initial
involvement of the tibial and popliteal segments
appears to be more important in determining long-
term outcome, an observation that is not reflected by
uniform scoring of the lower extremity venous seg-
ments. Furthermore, the relative importance of the
individual tibial and peroneal veins is unknown and
can not be ascertained by collective scoring of the calf
veins. The importance of occlusive versus nonocclu-
sive thrombus in determining outcome is similarly
unclear. Although others7 have found no association
between the presence of occlusive thrombus and
long-term outcome, the correlation between CVD
classification and both the degree of initial tibial
thrombosis and final popliteal obstruction suggests
that this distinction may have merit. Finally, because
any scoring system that attempts to quantify throm-
bus load within an entire limb will be relatively insen-
sitive to the dynamic changes that occur in individual
Table II. Natural history determinants of chronic venous disease classification
Class 0 Class 1 Class 3 Class 4 Class 5
(n = 20) (n = 13) (n = 25) (n = 13) (n = 2) r* P
Initial thrombus score† 5.7 (± 1.0) 6.5 (± 1.2) 8.8 (± 0.9) 5.5 (± 1.2) 8.0 (± 0.0) .1 .3
Final thrombus score† 0.6 (± 0.2) 1.0 (± 0.3) 2.1 (± 0.5) 0.8 (± 0.3) 1.5 (± 1.5) .2 .09
Percent recanalization† 86 (± 6.3) 78 (± 8.9) 76 (± 6.2) 85 (± 5.6) 81 (± 18.8) –.2 .08
50% Recanalization time† (months) 2.1 (± 0.4) 1.7 (± 0.5) 4.6 (± 1.3) 5.9 (± 3.0) 4.8 (± 4.7) .1 .1
Percent with rethrombosis‡ 70% 61.5% 60% 61.5% 100% –.2 .2
Reflux score† 1.2 (± 0.3) 2.2 (± 0.6) 2.4 (± 0.3) 2.5 (± 0.5) 4.0 (± 0) .3 .003
Follow-up time (months)† 51 (± 4.5) 59 (± 7.2) 56 (± 5.9) 58 (± 7.2) 64 (± 38.7) .05 .7
*Correlation coefficient was determined with Spearman rank correlation.
†Results are presented as mean (± standard error of the mean).
‡Percent of limbs with an interval increase in total thrombus score.
Table III. Multivariate determinants of chronic venous disease classification
Variable Coefficient 95% Confidence interval P
Presentation model Initial tibial score 0.3 0.1 to 0.5 .04
Follow-up model Final popliteal score 1.0 0.2 to 1.8 .01
Final reflux score 0.3 0.1 to 0.5 .008
Months to 50% recanalization 0.06 0.0 to 0.12 .06
venous segments, such systems are limited in their
ability to quantitatively follow the natural history of
an acute thrombus.
Other information that could potentially predict
outcome on the basis of features noted at the time of
presentation include demographic and thrombotic
risk factors. Although the current study began before
the development of quantitative NA-ISCVS/SVS risk
scores, none of the risk factors for acute DVT were
significantly associated with long-term outcome.
Female patients did tend to recanalize more rapidly
and to have a lower incidence rate of severe post-
thrombotic skin manifestations, but gender was not
independently predictive of ultimate CVD classifica-
tion. Although not statistically significant in this 
small study, the possibility of a better outcome in
female patients warrants further investigation. Gender
differences in the fibrinolytic system have been
described,19-21 with reports of higher plasminogen
levels, lower plasminogen activator inhibitor levels,
and increased fibrinolytic activity in female patients
both at the baseline and after venous occlusion.20
Despite the limitations in predicting outcome
from clinical features of a patient’s presentation, this
study does confirm many previously reported aspects
of the natural history of acute DVT. That is, most
thrombi eventually recanalize,22,23 and although most
patients have some post-thrombotic manifestations,
the incidence of ulceration is low.11,24 Furthermore,
this study confirms the role of both valvular incompe-
tence and residual obstruction in the pathophysiology
of the post-thrombotic syndrome.25,26 As previously
demonstrated by Johnson et al,26 persistent obstruc-
tion of the distal deep venous segments appears to be
particularly important in the pathogenesis of the post-
thrombotic syndrome. The current study suggests
that the severity of symptoms is independently related
to both the degree of valvular incompetence and
popliteal obstruction, with the coefficients of the
regression model implying that each 1-point incre-
ment in total reflux or final popliteal scores is associ-
ated with the respective increases of 0.3 and 1.0 in
CVD classification.
These data also suggests that a patient’s response
to an acute DVT is more important in determining
outcome than is the initial appearance of the throm-
bus. We have previously identified the rate of
recanalization27,28 and the occurrence of recurrent
thrombotic events29 as important determinants of
valve competence in individual venous segments. In
this study, we have examined these factors in the
entire extremity and have attempted to relate them
to the clinical outcome. As suggested by its role in
determining segmental valvular competence, the
time to 50% recanalization was a predictor of clinical
CVD classification. The multivariate model suggests
that the outcome worsens by 0.2 CVD classification
units for every 3 months required to achieve 
50% recanalization. Although recurrent events, as
defined by interval increases in thrombotic score
determined by ultrasound, occurred in 64% of
extremities, they were not correlated with a worse
clinical outcome. This finding is in distinct contrast
to those of Prandoni et al7 who found a 6-fold
increased risk of the post-thrombotic syndrome
among the 10% of patients with an ipsilateral recur-
rence. As neither global or segmental increases in
thrombus score were correlated with outcome in
this study, the factors that determine clinically rele-
vant rethrombosis need to be further evaluated.
Similar to the first episode of DVT, it is conceivable
that the segmental location of recurrent events is
important in determining outcome.
The ability to predict long-term outcome after
an episode of acute DVT therefore is limited at pre-
sent. It does appear that the subsequent course of a
thrombus is much more important in the determi-
nation of CVD classification than is its initial appear-
ance. Among the factors that can currently be
defined at the time of presentation, only involve-
ment of the tibial segments was significantly corre-
lated with long-term outcome, and the predictive
value of this model was quite low. Furthermore,
although final popliteal score, final reflux score, and
time to 50% recanalization are related to ultimate
CVD classification, the predictive value of models
that incorporate these factors was also limited with
an R2 value of only 0.29. Other potential determi-
nants of outcome clearly remain to be identified. A
more precise definition of clinically relevant recur-
rent thrombotic events and mechanisms to prospec-
tively identify patients who are at risk for recurrent
thrombosis or delayed recanalization might also
improve the ability to predict long-term outcome.
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